“Asthma with Metabolic Comorbidity: Management Challenges and Novel Treatment Options”

Speaker:

Katherine Cahill, M.D., B.S.
Assistant Professor of Allergy, Pulmonary and Critical Care Medicine
Medical Director of Clinical Asthma Research
Vanderbilt University Medical Center

About Katherine Cahill:

Dr. Cahill holds a bachelor's degree in biology from Pepperdine University in California. She earned her medical education from Robert Wood Johnson Medical School in Rutgers. She received internal medicine residency training at Beth Israel Deaconess Medical Center followed by fellowship training at Brigham and Women's Hospital and Harvard Medical School, all in Boston. She is board certified in internal medicine and allergy and immunology. 

Dr. Cahill's research interests focus on the mechanisms of adult asthma with a primary interest in severe asthma phenotypes including aspirin-exacerbated respiratory disease (AERD) and obesity-associated asthma. She has published seminal work on the development of new therapies, including the use of tyrosine kinase inhibitors in severe asthma, and is pioneering work on the clinical benefit and anti-inflammatory effects of GLP-1R agonist therapies such as liraglutide and semaglutide in respiratory disease. Through her research efforts, Dr. Cahill provides patients in middle Tennessee and surrounding areas with access to national clinical research studies supported by the National Institutes of Health and the American Lung Association.

Dr. Cahill was recognized by the American Thoracic Society in 2021, with the Jo Rae Wright Award for her contribution to science. Dr. Cahill is a fellow of the American Academy of Allergy, Asthma, and Immunology and a member of the American Thoracic Society. She has presented lectures nationally and internationally throughout her career and published her findings in well-recognized journals in the allergy, pulmonology and immunology fields.